This SiteProfile is a report containing information on 4 years of U.S. Food & Drug Administration inspections at the Chongqing Lummy Pharmaceutical facility located in Chongqing, China.
This report is updated through .
Site profiles provide key FDA inspection metrics as well as a comprehensive history of all FDA inspections of the site since the year 2013. Site profiles have proven to be useful as part of the due diligence process as companies evaluate a site for validation, acquisition, partnership, and/or benchmarking purposes. If you will be validating a large number of sites on an on-going basis, you should consider Enforcement Analytics or contact us at sales@FDAzilla.com.
Once you check out, you will receive an email (usually within minutes) with a link to download the site profile.